Cargando…
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
BACKGROUND: Drug repurposing is a swift, safe, and cheap drug discovery method. Melanoma disorders present low survival and high mortality rates and are challenging to diagnose and treat. Moreover, there is a high volume of worldwide investigations that are attempting to find melanoma-related genes...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584997/ https://www.ncbi.nlm.nih.gov/pubmed/31221082 http://dx.doi.org/10.1186/s10020-019-0098-x |